settings where healthcare is delivered (including nursing homes and home health). This guidance provides a framework for facilities to implement select infection prevention and control practices (e.g., universal source control) based on their individual circumstances (e.g., levels of community transmission). Updates were made to reflect the high levels of vaccine-and infection-induced immunity and the availability of effective treatments and prevention tools. This interim guidance has been updated based on currently available information about COVID-19 and the current situation in the United States. Clarified the types of long-term care settings for whom the healthcare infection prevention and control recommendations apply.Updated screening testing recommendations for nursing home admissions.
Archived the Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes and special considerations for nursing homes not otherwise covered in Sections 1 and 2 were added to Section 3: Setting-specific considerations.Updated to note that, in general, asymptomatic patients no longer require empiric use of Transmission-Based Precautions following close contact with someone with SARS-CoV-2 infection.Clarified that screening testing of asymptomatic healthcare personnel, including those in nursing homes, is at the discretion of the healthcare facility.Updated recommendations for testing frequency to detect potential for variants with shorter incubation periods and to address the risk for false negative antigen tests in people without symptoms.Updated circumstances when universal use of personal protective equipment should be considered.Updated circumstances when use of source control is recommended.Updated to note that vaccination status is no longer used to inform source control, screening testing, or post-exposure recommendations.
0 kommentar(er)
